Agilent Brings Expanded PD-L1 Testing and Digital Pathology Workflows to USCAP 2026
The company will highlight a new PD-L1 indication for ovarian cancer and end-to-end digital pathology workflows at the annual meeting in San Antonio.
Read More
Search Results for: lung cancer
Breath Test Using Carbon Isotopes May Quickly Confirm Bacterial Infections
A proof-of-concept study shows that bacteria-metabolized molecules enriched with carbon-13 produce detectable exhaled CO2, enabling rapid infection identification with inexpensive infrared scanners.
Read More
NeoGenomics’ PanTracer LBx Test Qualifies for Medicare Coverage Under MolDX Policy
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
Read More
Hepion Pharmaceuticals Licenses ctRNA Biomarker Assay for Liver Cancer Detection
Hepion Pharmaceuticals has licensed a circulating tumor RNA assay from Cirna Diagnostics for early detection of hepatocellular carcinoma in high-risk patients, expanding its liquid biopsy portfolio for liver cancer.
Read More
Protein Biomarker Tests May Detect Cancer Earlier Than DNA-Based Methods
20/20 BioLabs argues a tiered screening approach—starting with protein-based tests before moving to circulating tumor DNA testing or imaging—could improve early-stage detection and lower costs.
Read More